Search Results - "Carmona, Juan Antonio"

Refine Results
  1. 1

    Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal by Garda-Carmona, Juan Antonio, Pappa, Sofia

    Published in Drug, healthcare and patient safety (30-09-2023)
    “…Paliperidone palmitate 3-monthly (PP3M), an approved maintenance treatment for patients with schizophrenia, was the first long-acting antipsychotic injectable…”
    Get full text
    Journal Article
  2. 2

    Sex differences between CRF1 receptor deficient mice following naloxone-precipitated morphine withdrawal in a conditioned place aversion paradigm: implication of HPA axis by García-Carmona, Juan-Antonio, Baroja-Mazo, Alberto, Milanés, María-Victoria, Laorden, María Luisa

    Published in PloS one (01-04-2015)
    “…Extinction period of positive affective memory of drug taking and negative affective memory of drug withdrawal, as well as the different response of men and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Role of CRF1 receptor in post-incisional plasma extravasation and nociceptive responses in mice by Romero, Asunción, García-Carmona, Juan-Antonio, Laorden, María-Luisa, Puig, Margarita M.

    Published in Toxicology and applied pharmacology (01-10-2017)
    “…The corticotropin-releasing factor (CRF) is involved in a number of physiological functions including pain perception. The purpose of this study was to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    CP-154,526 Modifies CREB Phosphorylation and Thioredoxin-1 Expression in the Dentate Gyrus following Morphine-Induced Conditioned Place Preference by García-Carmona, Juan-Antonio, Camejo, Daymi M, Almela, Pilar, Jiménez, Ana, Milanés, María-Victoria, Sevilla, Francisca, Laorden, María-Luisa

    Published in PloS one (27-08-2015)
    “…Corticotropin-releasing factor (CRF) acts as neuro-regulator of the behavioral and emotional integration of environmental and endogenous stimuli associated…”
    Get full text
    Journal Article
  7. 7

    Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc) by Almela, Pilar, Navarro-Zaragoza, Javier, García-Carmona, Juan-Antonio, Mora, Lucía, Hidalgo, Juana, Milanés, María-Victoria, Laorden, María-Luisa

    Published in PloS one (10-10-2012)
    “…Stress induces the release of the peptide corticotropin-releasing factor (CRF) into the ventral tegmental area (VTA), and also increases dopamine (DA) levels…”
    Get full text
    Journal Article
  8. 8

    Sympathetic activity induced by naloxone-precipitated morphine withdrawal is blocked in genetically engineered mice lacking functional CRF1 receptor by García-Carmona, Juan-Antonio, Martínez-Laorden, Elena, Milanés, María-Victoria, Laorden, María-Luisa

    Published in Toxicology and applied pharmacology (15-02-2015)
    “…There is large body evidence indicating that stress can lead to cardiovascular disease. However, the exact brain areas and the mechanisms involved remain to be…”
    Get full text
    Journal Article
  9. 9

    Catalytic Evaluation of Hafnium Modified SiO2 for the Dehydration of Alcohols by Esteban Benito, Heriberto, García Alamilla, Ricardo, García Serrano, Luz Arcelia, Paraguay Delgado, Francisco, Carmona García, Juan Antonio

    Published in Applied sciences (01-07-2023)
    “…The influence of hafnium metal (Hf) and sulfate ions (SO42−) on the acidic properties of SiO2 mesopores synthesized by a non-hydrothermal method was studied…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Brain stress system response after morphine-conditioned place preference by García-Carmona, Juan-Antonio, Milanés, María-Victoria, Laorden, María-Luisa

    “…This study examined the involvement of the brain stress system in the reinforcing effects of morphine. One group of mice was conditioned to morphine using the…”
    Get full text
    Journal Article
  13. 13

    Case report: Endovascular embolization of a cerebral pseudoaneurysm caused by SARS-CoV2 infection by García-Carmona, Juan Antonio, von Quednow, Enzo, Hernández-Fernández, Francisco, Molina-Nuevo, Juan David, García-García, Jorge, Palao, María, Segura, Tomás

    Published in Frontiers in neurology (04-10-2022)
    “…BackgroundSevere COVID-19 has been shown to produce convulsions, encephalitis, Guillain-Barré syndrome, or cerebrovascular disease. However, only 4 case…”
    Get full text
    Journal Article
  14. 14

    Correction: Role of Corticotropin-Releasing Factor (CRF) Receptor-1 on the Catecholaminergic Response to Morphine Withdrawal in the Nucleus Accumbens (NAc) by Almela, Pilar, Navarro-Zaragoza, Javier, García-Carmona, Juan-Antonio, Mora, Lucía, Hidalgo, Juana, Milanés, María-Victoria, Laorden, María-Luisa

    Published in PloS one (17-05-2013)
    “…The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (2013) Correction: Role of…”
    Get full text
    Journal Article
  15. 15

    Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort by Martínez-Andrés, Juan Andrés, García-Carmona, Juan Antonio

    Published in International clinical psychopharmacology (01-05-2020)
    “…Clozapine, an antipsychotic developed in 1958, is considered the gold standard and the treatment of choice in treatment-resistant schizophrenia despite its…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Crosstalk between G protein-coupled receptors (GPCRs) and tyrosine kinase receptor (TXR) in the heart after morphine withdrawal by Almela, Pilar, García-Carmona, Juan-Antonio, Martínez-Laorden, Elena, Milanés, María-Victoria, Laorden, María-Luisa

    Published in Frontiers in pharmacology (01-01-2013)
    “…G protein-coupled receptors (GPCRs) comprise a large family of membrane receptors involved in signal transduction. These receptors are linked to a variety of…”
    Get full text
    Journal Article
  18. 18

    Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype by Georgiou, Polymnia, Zanos, Panos, Garcia-Carmona, Juan-Antonio, Hourani, Susanna, Kitchen, Ian, Laorden, Maria-Luisa, Bailey, Alexis

    Published in Neuropharmacology (01-06-2016)
    “…The major challenge in treating methamphetamine addicts is the maintenance of a drug free-state since they experience negative emotional symptoms during…”
    Get full text
    Journal Article
  19. 19

    The oxytocin analogue carbetocin prevents priming-induced reinstatement of morphine-seeking: Involvement of dopaminergic, noradrenergic and MOPr systems by Georgiou, Polymnia, Zanos, Panos, Garcia-Carmona, Juan-Antonio, Hourani, Susanna, Kitchen, Ian, Kieffer, Brigitte L, Laorden, Maria-Luisa, Bailey, Alexis

    Published in European neuropsychopharmacology (01-12-2015)
    “…Abstract Relapse to illicit drug-seeking following abstinence is a major challenge for the treatment of addiction as no effective pharmacotherapy is available…”
    Get full text
    Journal Article
  20. 20